Retatrutide

Research Overview

Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors. It is being studied in metabolic research models for its potential effects on energy expenditure, appetite regulation, and glucose/lipid metabolism.

Mechanism of Action (Laboratory Research)

Research indicates that simultaneous activation of GLP-1, GIP, and glucagon receptors may enhance thermogenesis and produce effects on body weight and metabolic parameters in preclinical metabolic disease models.

Key Published Research Areas

• Triple receptor agonism and energy expenditure
• Appetite regulation and body weight effects in metabolic models
• Glucose and lipid metabolism research
• Comparative studies with dual agonists in obesity models

Note: All referenced research is from metabolic studies. Sold strictly for laboratory research use only.